Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Oncotarget. 2019 Oct 15;10(57):6043. doi: 10.18632/oncotarget.27256.

¹ Unit of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
² Unit of Tumor Genomics, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
³ Unit of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
⁴ Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
⁵ Department of Clinical and Biomedical Sciences Luigi Sacco, University of Milan, Milan, Italy.
⁶ Department of Statistics and Quantitative Methods, Division of Biostatistics, Epidemiology and Public Health, Laboratory of Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
⁷ Department of Clinical Sciences, Section of Radiology, University of Parma, Milan, Italy.
⁸ Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.5210.].